Underlying mechanism is unique location of CDH17 at tight junction between normal intestinal epithelial cells and thereby ‘masked’ in healthy tissues, while cancer cells’ lack of polarity exposes CDH17 expression enhancing susceptibility to CAR-T-mediated killing. Here, CDH17 is linked to cancer.